New York adviser sentenced to six months for insider trading

Tibor Klein also will pay $20,000 fine for trading on 2010 Pfizer acquisition

Feb 13, 2018 @ 12:11 pm

By InvestmentNews

Tibor Klein, a Long Island, N.Y., investment adviser, was sentenced to six months in prison on Monday after pleading guilty to insider trading in connection with Pfizer Inc's $3.6 billion acquisition of King Pharmaceuticals Inc. in 2010.

U.S. District Judge Joan Azrack sentenced Mr. Klein, 44, in federal court in Brooklyn, N.Y., according to a Reuters report. Last July, Mr. Klein had pleaded guilty to one count of conspiracy to commit securities fraud.

Mr. Klein, the founder of Valley Stream, N.Y.-based Klein Financial Services, also was sentenced to six months of house arrest and 250 hours of community service, according to Reuters, and ordered to forfeit $37,225 and pay a $20,000 fine.

The government said Mr. Klein learned about the deal from Robert Schulman, then a partner at the law firm Hunton & Williams in Washington, who had represented King Pharmaceuticals. Mr. Klein purchased shares in King for himself, Mr. Schulman and clients, and informed a friend, Michael Shechtman, a Florida stockbroker, about the deal. Prosecutors say the insider trading resulted in more than $400,000 of overall illegal profit.

Mr. Schulman, of McLean, Va., was convicted of insider trading last March. Mr. Shechtman, a former broker at Ameriprise, pleaded guilty in Brooklyn in November 2014 to conspiracy and has cooperated with prosecutors. He has not been sentenced.

The Securities and Exchange Commission filed related civil charges against Mr. Klein and Mr. Shechtman in September 2013, but that case was put on hold until the criminal case was resolved.

0
Comments

What do you think?

View comments

Recommended for you

Sponsored financial news

Featured video

Events

What's the first thing advisers should do when they get home from a conference?

After attending a financial services conference, advisers can be overwhelmed by options, choices and tools. What's the first thing they should do when they get back to their office?

Latest news & opinion

Is Fidelity competing with retirement plan advisers?

As the Boston-based mutual fund giant expands the products and services it brings to the retirement market, some financial advisers say the firm is encroaching on their turf.

Gun violence hits investment strategies, sparks political debates with advisers

Screening out weapons companies has limited downside.

Whistleblower said to collect $30 million in JPMorgan case

The bank did not properly disclose that it was steering asset-management customers into investments that would be profitable for JPMorgan Chase.

Social Security underpaid 82% of dually entitled widows and widowers

Agency failed to tell survivors that they could switch to a higher retirement benefit later.

If Finra eases firm oversight of outside business activities, broker-dealers could lose revenue

Brokerage firms would no longer be able to charge reps for supervising nonaffiliated RIAs.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print